Phenserine: Began Phase I testing

Axonyx Inc. (AXYX), New York, N.Y. Product: Phenserine Business: Neurological Therapeutic category: Neurotransmission Target: Acetylcholinesterase Description: Reversible acetylcholinesterase inhibit...